Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis
Objective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000193.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832581832766390272 |
---|---|
author | Pedro Oliveira Robert G Bristow Ananya Choudhury Ashwin Sachdeva Noel Clarke Hitesh Mistry Amin Ali Thiraviyam Elumalai BhanuPrasad Venkatesulu Lauren Hekman Esther Baena |
author_facet | Pedro Oliveira Robert G Bristow Ananya Choudhury Ashwin Sachdeva Noel Clarke Hitesh Mistry Amin Ali Thiraviyam Elumalai BhanuPrasad Venkatesulu Lauren Hekman Esther Baena |
author_sort | Pedro Oliveira |
collection | DOAJ |
description | Objective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical relapse-free survival (bRFS) and distant metastases rate; secondary endpoints included clinical and pathological features.Results Ten retrospective cohort studies were identified, six reported HRs for bRFS between PZ and TZ tumours. Patients with TZ tumours had significantly better bRFS (pooled HR 0.57 (0.47, 0.68)) than those with PZ tumours. Two studies reported a lower proportion of distant metastasis in patients diagnosed with TZ tumours compared with PZ tumours (1.5% vs 4.9% (median follow-up 7.0 years) and 0% vs 5% (median follow-up 7.8 years)). PZ tumours presented higher Gleason group and T staging more frequently, while TZ tumours were associated with higher prostate specific antigen levels at diagnosis.Conclusion PZ tumours were associated with poorer prognostic clinical features and outcomes. Despite adjusting for poor prognostic clinical features, PZ tumours consistently showed worse clinical outcomes than TZ tumours. Our systematic review underscores the need for further research comparing PZ and TZ prostate cancer to understand the underlying differences and refine clinical practice. |
format | Article |
id | doaj-art-d688267134774f6b9052fd06bfbc51fb |
institution | Kabale University |
issn | 2752-7948 |
language | English |
publishDate | 2024-07-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Oncology |
spelling | doaj-art-d688267134774f6b9052fd06bfbc51fb2025-01-30T09:55:09ZengBMJ Publishing GroupBMJ Oncology2752-79482024-07-013110.1136/bmjonc-2023-000193Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysisPedro Oliveira0Robert G Bristow1Ananya Choudhury2Ashwin Sachdeva3Noel Clarke4Hitesh Mistry5Amin Ali6Thiraviyam Elumalai7BhanuPrasad Venkatesulu8Lauren Hekman9Esther Baena10Department of Pathology, The Christie Hospital NHS Trust, Manchester, UKTranslational Oncogenomics, Cancer Research UK Manchester Centre, The University of Manchester, Manchester, UKDivision of Cancer Sciences, University of Manchester, Manchester, UKDepartment of Surgery, The Christie Hospital NHS Trust, Manchester, UK5 The Christie NHS Foundation Trust, Manchester, Manchester, UKSchool of Health Sciences, The University of Manchester, Manchester, UKOncology Department, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UKOncology Department, Addenbrooke`s Hospital, Cambridge, UKRadiation Oncology Department, Loyola University Chicago, Chicago, Illinois, USADepartment of Urology, Loyola University Chicago, Chicago, Illinois, USAProstate Oncobiology, Cancer Research UK Manchester Centre, The University of Manchester, Manchester, UKObjective To assess pathological characteristics, clinical features and outcomes of patients diagnosed with peripheral zone (PZ) and transition zone (TZ) prostate cancer after prostatectomy.Methods and analysis We systematically reviewed PubMed, EMBASE and MEDLINE. Primary endpoints were biochemical relapse-free survival (bRFS) and distant metastases rate; secondary endpoints included clinical and pathological features.Results Ten retrospective cohort studies were identified, six reported HRs for bRFS between PZ and TZ tumours. Patients with TZ tumours had significantly better bRFS (pooled HR 0.57 (0.47, 0.68)) than those with PZ tumours. Two studies reported a lower proportion of distant metastasis in patients diagnosed with TZ tumours compared with PZ tumours (1.5% vs 4.9% (median follow-up 7.0 years) and 0% vs 5% (median follow-up 7.8 years)). PZ tumours presented higher Gleason group and T staging more frequently, while TZ tumours were associated with higher prostate specific antigen levels at diagnosis.Conclusion PZ tumours were associated with poorer prognostic clinical features and outcomes. Despite adjusting for poor prognostic clinical features, PZ tumours consistently showed worse clinical outcomes than TZ tumours. Our systematic review underscores the need for further research comparing PZ and TZ prostate cancer to understand the underlying differences and refine clinical practice.https://bmjoncology.bmj.com/content/3/1/e000193.full |
spellingShingle | Pedro Oliveira Robert G Bristow Ananya Choudhury Ashwin Sachdeva Noel Clarke Hitesh Mistry Amin Ali Thiraviyam Elumalai BhanuPrasad Venkatesulu Lauren Hekman Esther Baena Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis BMJ Oncology |
title | Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis |
title_full | Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis |
title_fullStr | Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis |
title_full_unstemmed | Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis |
title_short | Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis |
title_sort | tale of two zones investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta analysis |
url | https://bmjoncology.bmj.com/content/3/1/e000193.full |
work_keys_str_mv | AT pedrooliveira taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT robertgbristow taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT ananyachoudhury taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT ashwinsachdeva taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT noelclarke taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT hiteshmistry taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT aminali taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT thiraviyamelumalai taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT bhanuprasadvenkatesulu taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT laurenhekman taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis AT estherbaena taleoftwozonesinvestigatingtheclinicaloutcomesandresearchgapsinperipheralandtransitionzoneprostatecancerthroughasystematicreviewandmetaanalysis |